Bonum Certa Men Certa

Pharma Patents Have Become Harder to Enforce, So IAM Together With the Patent Microcosm Sets Up Lobbying Events

IAM: When "alternative facts" are up for sale (if one can afford them)

Battistelli and IAM



Summary: The difficulty associated with enforcing certain types of patents (more so after Mayo and €§ 101) means that litigious attitudes and reliance on law firms are decreasing; IAM strikes back with another one of its many lobbying events (designed to shape public opinion and influence key decision-makers)

THE concept of patents is pretty much universal, but not all patents are created equal. There are different sorts of patents ("families") pertaining to or belonging to different domains. Speaking of them all as though they're the same is the recipe for meaningless debates. Not all patents, for example, are a matter of life or death. Ethical aspects apply in some cases; sometimes pure economics.



"Not all patents, for example, are a matter of life or death."As we discovered quite recently, EPO oppositions can crash companies. In other words, wrong decisions (or intentions) to grant can be truly harmful and pretty awful to workers. Things get pretty freaky when patents are being claimed on life itself. Forward Pharma lost 30% of its value (or valuation) in just one day at the end of January. This was due to an EPO decision. Yes, some sectors are over-reliant on patents; there's no question about it. Here's an example from two days ago: (in the UK)

Shares in Scancell Holdings PLC rose sharply on Friday morning as the company said its Moditope immunotherapy platform is to be granted a European patent.

Scancell shares were up 11% on Friday at 13.54 pence per share.


How good is this European Patent (EP)? Well, there's lack of certainty under Battistelli, so Scancell Holdings PLC might be the next Forward Pharma (a one-day collapse).

"What we have here is a cross-continental fight taken up to the ITC and failing, having heavily relied on a patent from the USPTO."Pacific Biosciences is meanwhile attempting to 'compete' by causing embargo of its rival, Oxford Nanopore. We wrote about it some days ago and received plenty of comments from people involved in this matter. It's yet another one of those ITC examples where patent litigation is geared towards embargoes and bankruptcies, not innovation. Here is what the face-saving press release said (striving to justify waste of shareholders' money, spent on litigation). This campaign of patent litigation by Pacific Biosciences backfired pretty badly. "Pacific Bio down 2% premarket on ITC patent ruling," Wall Street media stated shortly thereafter. To quote: "The ITC interpreted the term "single-molecule sequencing" as limited to sequencing-by-synthesis approaches, determining that Oxford's sequencing approach is not "single-molecule sequencing.""

What we have here is a cross-continental fight taken up to the ITC and failing, having heavily relied on a patent from the USPTO.

We have become increasingly supportive of the USPTO because it continues to deny patents on life and even software patents. PTAB helps and gravitates towards that. See the latest PTAB Life Sciences Report by John Cravero and Pharma Patents Blog writing about 35 U.S.C. €§ 101 rejections (not just based on Alice but also Mayo):

We’ve written previously about ex parte decisions of the Patent Trial and Appeal Board (PTAB) affirming patent eligibility rejections that seem to be inconsistent with the USPTO’s Subject Matter Eligibility Guidance. Apparently, applicants should be wary about appealing any rejection of a diagnostic method claim, because the PTAB may enter sua sponte patent eligibility rejections even if the examiner did not make a €§ 101 rejection.


Aside from €§ 101 there's also 35 U.S.C. €§ 102. Hospira, based on this blog post, wins again. MedCo's patent has been declared bogus as per €§ 102. To quote:

In the litigation, Hospira argued both (1) that the MedCo patents were invalid and (1) that Hospira’s proposed generic Angiomax drug would not infringe. The district court sided with MedCo on the first point (patents not invalid) but with Hospira on the second (patents not infringed). On appeal, the Federal Circuit has affirmed the non-infringement ruling but reversed on the on sale issue. The interesting portion is the on sale question.


Benjamin Anger and Jacob R. Rosenbaum wrote about it some days ago (very detailed).

"They get what they paid for. It's pure lobbying/marketing."As one can expect, the litigation 'industry' isn't particularly happy about that. Many patents are being invalidated, which must be causing decrease in demand for patents and lawsuits (their main "offerings" or "services" or "products").

There's a "Pharma and Biotech IP Summit" being organised by IAM and as one can expect, the bill for this lobbying event is being footed by the main participants. "Finnegan is a Gold sponsor of IAM Magazine," it says. There's therefore a paid-for 'talk' (marketing). This not only helps Finnegan control the 'debate'; it also keeps IAM on their 'good side' (maybe IAM will give Finnegan some more of these bogus 'rewards' or 'endorsements'). "Jen Roscetti will present "The View from the United States" at @IAM_magazine's #Pharma and #Biotech #IP Summit in London," Finnegan wrote the other day. They get what they paid for. It's pure lobbying/marketing.

"Either way, "Pharma and Biotech IP Summit" is an IAM sham. It's sponsored by and dominated by the patent microcosm."With all honesty, more people ought to speak out about IAM's "business model", which involves collecting cash, pushing agenda (in the form of 'news' or staged 'debates'), offering bogus 'endorsements', and issuing 'studies' for people like Battistelli (bolstering his lies). There's nothing benign about it. IAM is effectively a think tank and even some less senior insiders must have realise it. Several of them left, only to be replaced by relatively young and inexperienced writers. Tim Lince, it should be noted, is still listed as a writer at IAM, but he wrote nothing this year and only 1 (one!) blog post last year. Many writers left and perhaps associating with people Battistelli (as we last noted last night) won't save them but only cause further harm.

Either way, "Pharma and Biotech IP Summit" is an IAM sham. It's sponsored by and dominated by the patent microcosm. It's like a propaganda platform facilitated by Joff Wild and his cohorts. He did the same for UPC (with cash from the EPO's PR firm). ⬆

Recent Techrights' Posts

IBM "Efficiency" is Working One's Way to the Bottom of the Remuneration Scale While Hiding the Stealth Layoffs
People still leaving
Forbes Already Stopped Being a News Site. Now It's a Spam and Propaganda Platform for "Paying Partners" (Companies).
news from Forbes became very scarce
Soap Opera of NVIDIA Marketing in Mainstream Media (Overhyped GPUs and Mindless Buzzwords)
NVIDIA's shares lost about $100 in "value" (or 40% "market cap" decline) in 6-7 weeks
The Boss of Linus Torvalds Has Bad Taste, Takes More Money Connected to Traffickers of Underage Girls for Sexual Exploitation Under the Guise of "Tackling Fraud"
Nothing will ever teach Jim Zemlin that Jeffrey Epstein is bad [...] Even the wife of Mr. Epsteingate was wise enough to keep a distance from it. But not Mr. Zemlin, who profits from rehabilitating abusers.
 
KDE is Good for Everybody
If Plasma isn't for "beginners", then why does does Valve made it the sole default in SteamOS/Steam Deck and why is it still around after 30+ years without any major controversy?
US Office of Government Ethics: NVIDIA Insider Trading by the Dictator of the US, Stock Soon 50% Below Its Value in October
It's just a rigged market, taxpayers are forced to pay for it (to bail out 'shy' billionaires)
Microsoft Morale Low, Drives Workers Crazy
Only a total moron with no grasp of technology would believe the catch-all excuse
No, IBM Didn't Lay Off Just "Hundreds" in 2026
These companies are rapidly shrinking. They just know how to hide what's really going on.
Slopapers: The Issue of Slop 'Wallpapers' Flooding the Repository in KDE and More
it's just an excuse that calls fusion (without attribution or any mention of a licence) "training" or "hey hi" or "fair use" or "superintelligence"
Links 20/11/2026: "Anthropic IPO [Shows] the AI Bubble Finally Popping" and New Problems With Slop Copyright Infringement
Links for the day
Richard Stallman, Founder of the GNU Project and a Co-founder of the FSF, Still Working With the FSF to Abolish Microsoft's Restricted Boot
Jack M. Germain has just published a lengthy article about GNU Boot
GNU/Linux Has Gained a Lot in Western Europe
Eastern Europe is another matter
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Thursday, November 19, 2026
IRC logs for Thursday, November 19, 2026
It's All About Restricted Boot and Microsoft
Garrett is working with Microsoft staff towards Microsoft agenda
Intercontinental Brigading - Part XXXXXVII - UK Isn't Part of the US or Russia
We have plenty to cover in the coming years
Update on Pocock v. Software in the Public Interest, Inc. (26-1766)
Case reassigned
Calling Frauds "Frauds" is Not Illegal
We are still getting the same vibe; Americans do not understand free speech, even if their country has a First Amendment
Everything is "AI" Now
"More Open Than Open [...] I am constantly amazed at the flexibility of this single word.”
Microsoft Web Sites Paint Mass Layoffs as Opportunities for Those Impacted, Mass Layoffs Alleged to Follow in January (to 'Kill Off' Survivors)
Keeping Up Appearances
Microsoft Outages Accelerate Migrations to Free Software
More than one major outage lately
Richard Stallman's Talks Next Month (Tech de Ciudad de México)
Right now is a very good time to promote Software Freedom because of recent world events
WSJ Leadership Institute as Marketing Spam for Slop and GAFAM/IBM PR
What the heck is "WSJ Leadership Institute"?
Links 19/11/2026: "So Many Crucial Services Are Going Down" and "Government Tech Debt is a National Security Risk" (Outages Blamed on Slop Frenzy)
Links for the day
Gemini Links 19/11/2026: Friends, Slop Harms Learning, and IBM Plex Lagrange Fontpacks
Links for the day
Links 19/11/2026: "Ignorance Has Taken Over" and "Apocalypse Now, Again"
Links for the day
Richard Stallman Still Insists "They" is Plural, Suggests "Perse" Instead
this week
New Video Explains Why Software Patents Are Evil ("Why Software Patents Spark So Much Frustration")
Maybe some patent examiners (who don't mind a Facebook URL) can take a look
Intercontinental Brigading - Part XXXXXVI - Never Showing Up for Their Own Hearings, Just Paying Hired Guns in London to Act as Fall Guys and Proxies With No Comprehension of the Technical Issues (and Sometimes by Bullying Our Lawyers)
Without any qualifications in the subject at hand
Compatible With Software of 30 Years Ago
Old is not bad, sometimes old is better
NVIDIA Corporation Does Not Look Healthy
The bubble will be hard to re-inflate
Gemini Links 19/11/2026: Thinking About Thinking and Discord
Links for the day
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Wednesday, November 18, 2026
IRC logs for Wednesday, November 18, 2026
Lots of IBM Layoffs in Slovakia This Year
Slovakia and Europe at large
There May be Little or No Future for IBM Consulting
IBM is believed to be run by parasites
At Least Three RMS Talks Next Month in Mexico (Richard Stallman Has 8+ Talks in a Month)
And also - possibly with slop - in social control media
Mass Layoffs at Salesforce Foretold by Techrights
Salesforce is dead meat and it's not alone
Gemini Links 18/11/2026: Creativity, MFA Hype, and Presto Music
Links for the day
Links 18/11/2026: More GAFAM/Apple 'Clown Computing' Outages and Deutsche Bank Leak, Banks' Downtimes
Links for the day
Today The Register MS Showed Loyalty to the Pyramid Scheme With Homage of Paid Spam About "AI"
The Register MS is disavowed by its founder, who died a few years ago (The Register MS didn't even mention this)
Staff Union of the European Patent Office (SUEPO) Plans General Assembly Next Week, Vote Planned to Approve 7+ More Months of Strikes
The "Agenda" is the same as what we showed yesterday, but the pattern of the actions varies somewhat
IBM's Red Hat a Microsoft Reseller (Second Day in a Row)
If you want a replacement for Microsoft, look somewhere other than Red Hat
After the Bubble Pops the "AI Experts" (Formerly "Data Scientists" or Whatever) Will Rebrand Themselves Again
Remember blockchains and metaverse?
Links 18/11/2026: "Fossil Fuel Companies Are Undermining Democracy" and "Lawyer Up, Elon"
Links for the day
Intercontinental Brigading - Part XXXXXV - Acts of Hypocrisy (Doing What You Accuse Others of Doing)
connected to my criticism of "Restricted Boot"
Mainstream and Establishment Media Trying to Connect "Open Source" to White-Collar Crimes and Scandals at Fraudulent NVIDIA
An associate us said that "MIT lies to smear OSS"
Lawfare Will Continue in 2027
We're dealing with defiant Microsofters who wrongly assume that accurate reporting that causes them distress somehow makes them entitled to money
On the Concept of Moral Obligations to Make the World a Better Place for Everybody
The world generally becomes better when more people challenge the status quo rather than bow down to masters
Nadella Talks About 60,000 Microsoft Workers Having to Decide Whether to Leave (in the Next 2-3 Weeks), They've Been Put on Notice
Some parts of Microsoft are poised for severe cuts
IBM Moved From Selling Technology to Selling Its Buildings
IBM is trying very hard to silence/crush critics
Staff Union of the European Patent Office (SUEPO) Looking to Extend Industrial Actions and Strikes to Almost 1.5 Years
It says a lot about the media that for 1.5 years staff is on strike in the second-largest organisation in Europe and the media pretends it's not happening
Richard Stallman's Talk in Quito This Week (At Least 5 Talks After That)
He's having a busy end of year
Gemini Links 18/11/2026: "Love For Old Devices" and New Software/Slop-ware Releases
Links for the day
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Tuesday, November 17, 2026
IRC logs for Tuesday, November 17, 2026